95 related articles for article (PubMed ID: 17503250)
21. The benefit of pre- and post-challenge urine heavy metal testing: part 2.
Crinnion WJ
Altern Med Rev; 2009 Jun; 14(2):103-8. PubMed ID: 19594221
[TBL] [Abstract][Full Text] [Related]
22. Toxicological status of children with autism vs. neurotypical children and the association with autism severity.
Adams JB; Audhya T; McDonough-Means S; Rubin RA; Quig D; Geis E; Gehn E; Loresto M; Mitchell J; Atwood S; Barnhouse S; Lee W
Biol Trace Elem Res; 2013 Feb; 151(2):171-80. PubMed ID: 23192845
[TBL] [Abstract][Full Text] [Related]
23. Commentary on the abuse of metal chelation therapy in patients with autism spectrum disorders.
Brent J
J Med Toxicol; 2013 Dec; 9(4):370-2. PubMed ID: 24113859
[TBL] [Abstract][Full Text] [Related]
24. The scientific basis for chelation: animal studies and lead chelation.
Smith D; Strupp BJ
J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of DMSA Therapy in a Sample of Arab Children with Autistic Spectrum Disorder.
Blaucok-Busch E; Amin OR; Dessoki HH; Rabah T
Maedica (Bucur); 2012 Sep; 7(3):214-21. PubMed ID: 23400264
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():17. PubMed ID: 19852790
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.
Adams JB; Baral M; Geis E; Mitchell J; Ingram J; Hensley A; Zappia I; Newmark S; Gehn E; Rubin RA; Mitchell K; Bradstreet J; El-Dahr J
BMC Clin Pharmacol; 2009 Oct; 9():16. PubMed ID: 19852789
[TBL] [Abstract][Full Text] [Related]
28. Integrative medicine and the role of modified citrus pectin/alginates in heavy metal chelation and detoxification--five case reports.
Eliaz I; Weil E; Wilk B
Forsch Komplementmed; 2007 Dec; 14(6):358-64. PubMed ID: 18219211
[TBL] [Abstract][Full Text] [Related]
29. American College of Medical Toxicology position statement on post-chelator challenge urinary metal testing.
American College of Medical Toxicology
J Med Toxicol; 2010 Mar; 6(1):74-5. PubMed ID: 20354920
[No Abstract] [Full Text] [Related]
30. Mercury and Autism Spectrum Disorder: Exploring the Link through Comprehensive Review and Meta-Analysis.
Stojsavljević A; Lakićević N; Pavlović S
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137565
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of Lead, Mercury, Arsenic, Cadmium, Manganese, and Aluminum in the Blood of Pakistani Children with and without Autism Spectrum Disorder and Their Associated Factors.
Rahbar MH; Ibrahim SH; Azam SI; Hessabi M; Karim F; Kim S; Zhang J; Gulzar Ali N; Loveland KA
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444373
[TBL] [Abstract][Full Text] [Related]
32. Associations of Metabolic Genes (
Rahbar MH; Samms-Vaughan M; Saroukhani S; Bressler J; Hessabi M; Grove ML; Shakspeare-Pellington S; Loveland KA; Beecher C; McLaughlin W
Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546147
[TBL] [Abstract][Full Text] [Related]
33. Interaction between a Mixture of Heavy Metals (Lead, Mercury, Arsenic, Cadmium, Manganese, Aluminum) and
Rahbar MH; Samms-Vaughan M; Lee M; Zhang J; Hessabi M; Bressler J; Bach MA; Grove ML; Shakespeare-Pellington S; Beecher C; McLaughlin W; Loveland KA
Res Autism Spectr Disord; 2020 Nov; 79():. PubMed ID: 33193808
[TBL] [Abstract][Full Text] [Related]
34. Concentrations of Lead, Mercury, Arsenic, Cadmium, Manganese, and Aluminum in Blood of Romanian Children Suspected of Having Autism Spectrum Disorder.
Hessabi M; Rahbar MH; Dobrescu I; Bach MA; Kobylinska L; Bressler J; Grove ML; Loveland KA; Mihailescu I; Nedelcu MC; Moisescu MG; Matei BM; Matei CO; Rad F
Int J Environ Res Public Health; 2019 Jun; 16(13):. PubMed ID: 31261817
[TBL] [Abstract][Full Text] [Related]
35. Interaction between manganese and
Rahbar MH; Samms-Vaughan M; Lee M; Christian MA; Bressler J; Hessabi M; Grove ML; Shakespeare-Pellington S; Desai CC; Reece JA; Loveland KA; Beecher C; McLaughlin W; Boerwinkle E
Res Autism Spectr Disord; 2018 Nov; 55():50-63. PubMed ID: 30930959
[TBL] [Abstract][Full Text] [Related]
36. Systematic Assessment of Research on Autism Spectrum Disorder (ASD) and Mercury Reveals Conflicts of Interest and the Need for Transparency in Autism Research.
Kern JK; Geier DA; Deth RC; Sykes LK; Hooker BS; Love JM; Bjørklund G; Chaigneau CG; Haley BE; Geier MR
Sci Eng Ethics; 2017 Dec; 23(6):1691-1718. PubMed ID: 29119411
[TBL] [Abstract][Full Text] [Related]
37. Mass spectrometry as a tool for studying autism spectrum disorder.
Woods AG; Ngounou Wetie AG; Sokolowska I; Russell S; Ryan JP; Michel TM; Thome J; Darie CC
J Mol Psychiatry; 2013; 1(1):6. PubMed ID: 25408899
[TBL] [Abstract][Full Text] [Related]
38. Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
Lee YJ; Oh SH; Park C; Hong M; Lee AR; Yoo HJ; Shin CY; Cheon KA; Bahn GH
Clin Psychopharmacol Neurosci; 2014 Apr; 12(1):19-30. PubMed ID: 24851117
[TBL] [Abstract][Full Text] [Related]
39. Environmental toxicants and autism spectrum disorders: a systematic review.
Rossignol DA; Genuis SJ; Frye RE
Transl Psychiatry; 2014 Feb; 4(2):e360. PubMed ID: 24518398
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
